'Biomedical Innovation Can Come From Anywhere,' Says JNJ Innovation Head
Richard Mason, head of Johnson & Johnson Innovation, London (EMEA), talks to Scrip senior writer, Lucie Ellis, about why R&D innovation hubs are still necessary to boost new scientific developments in the healthcare sector.
You may also be interested in...
Johnson & Johnson's new regional "innovation centres" will expand on the company's success with the US Janssen Labs project that opened earlier this year in San Diego to assist life science startups and connect the pharmaceutical company to promising new therapeutics, medical devices and consumer healthcare products (scripintelligence.com, 20 January 2012).
A selection of articles you might have missed from July 2020, including exclusive interviews with industry leaders and a review of Q2 financing statistics.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.